- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT07567937
Effects of Exercise and Short Term Rapid Weight Loss on Whole Blood Cells and Lymphocyte Subsets in Highly Trained National Level Wrestlers (EX-RWL-Lymphoc)
Effects of Exercise and Short-Term Rapid Weight Loss on Whole Blood Cells and Lymphocyte Subsets in Highly Trained National-Level Wrestlers: A Two-Phase Repeated-Measures Study
Wrestling is a weight-classified sport in which athletes frequently apply rapid weight loss (RWL) strategies prior to competition. While the performance-related consequences of RWL have been widely investigated, its combined effects with exercise on hematological parameters and immune cell profiles remain insufficiently understood. Therefore, this study aims to examine the effects of short-term weight loss and exercise on whole blood cell parameters and lymphocyte subsets in elite wrestlers.
Nine elite male wrestlers actively competing in the senior category (mean age: 22.90 ± 5.15 years; mean height: 1.75 m) voluntarily participated in this study. Athletes will achieve an average body mass reduction of 4.3% over a five-day period. Venous blood samples will be collected at 09:30 a.m. in a fasted state during two experimental phases: (1) Exercise-only phase, with blood sampling before and after exercise (BRWL1 and BRWL2); (2) Exercise plus weight loss phase, following the five-day weight loss period, with blood sampling before and after exercise (ARWL1 and ARWL2). Complete blood count parameters will be analyzed using an automated hematology analyzer, while lymphocyte subsets (CD3+, CD4+, CD8+, CD19+, CD16/56+) will be assessed by flow cytometry. Statistical analyses will be performed with a significance level set at p < 0.05.
Przegląd badań
Status
Warunki
Interwencja / Leczenie
Szczegółowy opis
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
Ankara
-
Ankara, Ankara, Turcja (Türkiye), 06000
- Ankara Yildirim Beyazit University Sports Sciences Laboratory
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
- Dorosły
Akceptuje zdrowych ochotników
Opis
Inclusion Criteria:
- Being between 18 and 35 years of age
- Being clinically healthy
- Actively competing in wrestling
- Having regular training experience
- No history of chronic disease
- No musculoskeletal injury that could affect performance
- Not using any medication or nutritional supplements that could influence hematological or biochemical parameters during the study period
- Willing to volunteer and provide written informed consent
Exclusion Criteria:
- Having any chronic disease (e.g., cardiovascular, metabolic, respiratory, or neurological disorders)
- Having a recent musculoskeletal injury that could affect exercise performance
- Using medications, ergogenic aids, or nutritional supplements that might influence hematological or biochemical parameters
- Having a history of smoking or alcohol abuse
- Failing to complete the testing procedures and training protocol required for the study
- Not providing written informed consent
- Withdrawing voluntarily during the study period
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Podstawowa nauka
- Przydział: Nielosowe
- Model interwencyjny: Zadanie sekwencyjne
- Maskowanie: Brak (otwarta etykieta)
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
|---|---|
|
Inny: Exercise
Participants performed a standardized wrestling exercise session on the first day of testing.
Venous blood samples were collected pre- and post-exercise (pre-exercise: BRWL1; post-exercise: BRWL2) to evaluate hematological and lymphocyte subset responses.
|
Standardized wrestling exercise session; pre- and post-exercise venous blood collected
Inne nazwy:
|
|
Inny: Exercise + Rapid Weight Loss
Participants underwent a 5-day rapid weight loss protocol prior to the exercise session, achieving an average body mass reduction of 4.3%.
On the fifth day, the same standardized exercise protocol as Group 1 was performed, and pre- and post-exercise blood samples were collected (pre-exercise: ARWL1; post-exercise: ARWL2) to evaluate hematological and lymphocyte subset responses.
|
Standardized wrestling exercise session; pre- and post-exercise venous blood collected
Inne nazwy:
5-day rapid weight loss protocol achieving average 4.3% body mass reduction
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Change in Leukocyte Count
Ramy czasowe: Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
|
Change in total white blood cell (WBC) count measured from pre- to post-exercise
|
Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
|
|
Change in Lymphocyte Percentage
Ramy czasowe: Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
|
Change in percentage of lymphocytes relative to total WBC count, measured from pre- to post-exercise.
|
Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
|
|
Change in CD3+ T Cell Count
Ramy czasowe: Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
|
Change in absolute count of CD3+ T lymphocytes measured from pre- to post-exercise.
|
Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
|
|
Change in CD4+ T Cell Count
Ramy czasowe: Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
|
Change in absolute count of CD4+ helper T lymphocytes measured from pre- to post-exercise.
|
Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
|
|
Change in CD8+ T Cell Count
Ramy czasowe: Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
|
Change in absolute count of CD8+ cytotoxic T lymphocytes measured from pre- to post-exercise.
|
Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
|
|
Change in CD19+ B Cell Count
Ramy czasowe: Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
|
Change in absolute count of CD19+ B lymphocytes measured from pre- to post-exercise.
|
Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
|
|
Change in CD16/56+ NK Cell Count
Ramy czasowe: Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
|
Change in absolute count of CD16/56+ natural killer (NK) cells measured from pre- to post-exercise.
|
Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Change in Creatine Kinase and Lactic Acid Levels
Ramy czasowe: Pre-exercise and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
|
Serum creatine kinase (CK) and lactic acid (LA) levels measured to assess anaerobic performance and muscle damage.
|
Pre-exercise and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
|
Współpracownicy i badacze
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- 2280
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Exercise
-
Rashid Latif Medical CollegeZakończonyZespół wielotorbielowatych jajnikówPakistan
-
Riphah International UniversityZakończonyFizjoterapia sportowaPakistan
-
Istanbul University - CerrahpasaRekrutacyjnyMotoryczny zespół ryzyka poznawczego | Osoby w podeszłym wieku (osoby w wieku 65 lat lub starsze) | Pacjent geriatryczny | Eksergowanie | Ćwiczenia nerwowo-mięśnioweTurcja (Türkiye)
-
Cukurova UniversityZakończonyZespół nadpobudliwości psychoruchowej z deficytem uwagi (ADHD)Turcja (Türkiye)
-
Sanidad de Castilla y LeónZakończonySkuteczność programu poprawiającego równowagę, mobilność i zapobiegającego upadkom u osób starszych.Przypadkowe upadkiHiszpania
-
INTI International UniversityUniversiti Pendidikan Sultan IdrisZakończony
-
The Hong Kong Polytechnic UniversityZakończonyBezsenność, podstawowyHongkong
-
Technical University of MunichZakończonyPobór energii | Zdrowie | Apetyt | Zachowania żywienioweNiemcy
-
Université Catholique de LouvainKU Leuven; Epsylon, ASBLJeszcze nie rekrutacja
-
Hacettepe UniversityRekrutacyjnyBóle krzyża | Skolioza idiopatyczna | PowięźTurcja (Türkiye)